Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind 60 Degrees Pharmaceuticals to start the first clinical trial of tafenoquine for babesiosis at Tufts Medical Center. Enrollment begins June 13, 2024.

Study Demonstrates Superiority of VeraForm® Marker Over Clips for Tumor Bed Delineation Accuracy SAN FRANCISCO, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Videra Surgical Inc., the developer of the novel adaptable tumor bed marker VeraForm® for breast cancer surgery, announced the presentation of an...

Metabolon to Develop accuGFR™ Kidney Function Test With Johns Hopkins and Tufts Medical Center More accurate kidney function test needed for chronic kidney disease“Silent killer” can go undetected without symptoms until patient has lost 90 percent of kidney function RESEARCH TRIANGLE PARK,...